(January 3, 2017, 12:51 PM EST) -- SAN FRANCISCO — A California federal judge on Dec. 22 once again granted in part a defendants’ motion to dismiss a putative class action seeking injunctive relief from Blue Shield of California’s denial of coverage for a drug to treat hepatitis C because Blue Shield has since amended its Harvoni policy and given notice to insureds that they can resubmit claims for treatment (Aram Homampour, et al. v. Blue Shield of California Life and Health Insurance Co., et al., No. 15-cv-05003, N.D. Calif.; 2016 U.S. Dist. LEXIS 177629)....